IL17A and psoriasis: Drugs targeting free IL-17 and its receptor are nowadays the most effective treatment in managing psoriasis [9,10].The release of EVs is a bidirectional communication between keratinocytes and neutrophils in the inflammatory state of psoriasis [11,12].